Palmer; Richard Michael John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Palmer; Richard Michael John.The latest application filed is for "2-oxy-benzoxazinone derivatives for the treatment of obesity".

Company Profile

0.13.13

Palmer; Richard Michael John - Hayes GB
PALMER; Richard Michael John - Beckenham GB
Palmer; Richard Michael John - Kent GB
Palmer; Richard Michael John - England GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2-oxy-benzoxazinone derivatives for the treatment of obesity Grant 8,877,750 - Hodson , et al. November 4, 2	2014-11-04
2-oxy-benzoxazinone Derivatives For The Treatment Of Obesity App 20110065697 - Hodson; Harold Francis ; et al.	2011-03-17
2-oxy-benzoxazinone derivatives for the treatment of obesity Grant 7,858,617 - Hodson , et al. December 28, 2	2010-12-28
2-oxy-benzoxazinone derivatives for the treatment of obesity Grant 7,825,113 - Hodson , et al. November 2, 2	2010-11-02
2-amino-benzoxazinone derivatives for the treatment of obesity Grant 7,776,853 - Hodson , et al. August 17, 2	2010-08-17
Thieno-(1,3)-oxazin-4-ones With Lipase Inhibiting Activity App 20090029978 - HODSON; Harold Francis ; et al.	2009-01-29
Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity Grant 7,407,954 - Hodson , et al. August 5, 2	2008-08-05
2-Oxy-Benzoxazinone Derivatives for the Treatment of Obesity App 20080161301 - Hodson; Harold Francis ; et al.	2008-07-03
Synthesis App 20070135641 - Palmer; Richard Michael John ; et al.	2007-06-14
Enzyme inhibitors Grant RE39,576 - Hodson , et al. April 17, 2	2007-04-17
Synthesis Grant 7,189,852 - Palmer , et al. March 13, 2	2007-03-13
Colonic release compostion App 20050220861 - Palmer, Richard Michael John ; et al.	2005-10-06
Form of renzapride hydrochloride hydrate and uses thereof App 20050209271 - Palmer, Richard Michael John ; et al.	2005-09-22
2-thio-4h-3, 1-benzoxazin-4-one derivatives for use as enzyme inhibitors Grant 6,916,808 - Downham , et al. July 12, 2	2005-07-12
Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity App 20050075336 - Hodson, Harold Francis ; et al.	2005-04-07
Synthesis App 20050049416 - Palmer, Richard Michael John ; et al.	2005-03-03
2-amino-benzoxazinone derivatives for the treatment of obesity Grant 6,656,934 - Hodson , et al. December 2, 2	2003-12-02
2-Oxy-benzoxazinone derivatives for the treatment of obesity App 20030195206 - Hodson, Harold Francis ; et al.	2003-10-16
2-amino-benzoxazinone derivatives for the treatment of obesity App 20030191123 - Hodson, Harold Francis ; et al.	2003-10-09
2-Oxy-benzoxazinone derivatives for the treatment of obesity Grant 6,624,161 - Hodson , et al. September 23, 2	2003-09-23
2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors App 20030176429 - Downham, Robert ; et al.	2003-09-18
2-Oxy-benzoxazinone derivatives for the treatment of obesity App 20030027821 - Hodson, Harold Francis ; et al.	2003-02-06
2-amino-benzoxazinone derivatives for the treatment of obesity App 20030013707 - Hodson, Harold Francis ; et al.	2003-01-16
Lectin compositions and uses thereof Grant 6,110,891 - Pusztai , et al. August 29, 2	2000-08-29
Amidino derivatives and their use as nitric oxide synthase inhibitors Grant 5,863,931 - Beams , et al. January 26, 1	1999-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.